The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10401-10408

  Taus, N S ^a   Mitchell, W J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VIRUS CELL INTERACTION; VIRUS LATENCY;

ANIMALS; ANTIGENS, VIRAL; GENES, IMMEDIATE-EARLY; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMEDIATE-EARLY PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); SCHWANN CELLS; TRANSCRIPTION, GENETIC; TRIGEMINAL GANGLION;

EID: 0034785566     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.21.10401-10408.2001     Document Type: Article

References (62)

1. Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice
2. Herpes simplex virus type 2 latency in the footpad of mice: Effect of acycloguanosine on the recovery of virus
3. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro
4. Latency comes of age for herpesviruses
5. Schwann cells of olfactory nerves contain glial fibrillary acidic protein and resemble astrocytes
6. Developmental analysis of the cytomegalovirus enhancer in transgenic animals
7. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice
8. Possible latent infection with herpes simplex virus in the mouse eye
9. Herpes simplex virus type 2 establishes latency in the mouse footpad
10. Pathogenesis of herpetic neuritis and ganglionitis in mice: Evidence for intra-axonal transport of infection
11. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization
12. Glial fibrillary acidic (GFA) protein in Schwann cells: Fact or artifact?
13. Analysis of the basal and inducible activities of the ICP0 promoter of herpes simplex virus type 1
14. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice
15. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides
16. Isolation of cDNA clones encoding rat glial fibrillary acidic protein: Expression in astrocytes and in Schwann cells
17. The latency-associated transcripts of herpes simplex virus: RNA in search of a function
18. Viral, neuronal, and immune factors which may influence herpes simplex virus latency and reactivation
19. Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice
20. Molecular basis of latency in pathogenic human viruses
21. Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection
22. Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro
23. Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation
24. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection
25. Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus
26. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus
27. An analysis of herpes simplex virus gene expression during latency establishment and reactivation
28. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection
29. Differentiation between a promoter and regulator regions of herpes simplex virus type 1: The functional domains and sequence of a movable regulator
30. Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice
31. Herpes simplex viral infection of the mouse trigeminal ganglion
32. Pathways of viral gene expression during acute neuronal infection with HSV-1
33. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1
34. Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice
35. Herpes simplex virus pathogenesis in transgenic mice is altered by the homeodomain protein Hox 1.3
36. Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia
37. Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice
38. Mapping of low abundance latency associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1
39. Herpes simplex virus type 1 replicates in the lens and induces cataracts in mice
40. Neuronal modulation of Schwann cell glial fibrillary acidic protein (GFAP)
41. Repression of viral transcription during herpes simplex virus latency
42. DNA binding by the herpes simplex virus type 1 ICP4 protein is necessary for efficient down regulation of the ICP0 promoter
43. Herpes simplex viruses and their replication
44. Detection of HSV nuclei acid sequences in the cornea during acute and latent ocular disease
45. Extraneural localization of herpes simplex virus in latently infected guinea pigs
46. Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: Comparison of primary and recurrent infection
47. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice
48. Retention of herpes simplex virus DNA sequences in the nuclei of mouse footpad keratinocytes after recovery from primary infection
49. Human herpesviruses: A consideration of the latent state
50. Latent herpes simplex virus in spinal ganglia of mice
51. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons
52. Light and electron microscopy of dorsal root, sympathetic, and enteric ganglia
53. Neuronal control of herpes simplex virus latency
54. Microscopic anatomy of peripheral nerve fibers
55. Peripheral nervous system demyelination with herpes simplex virus
56. Evidence of DNA: Protein interactions that mediate HSV-1 immediate early gene activation by VP16
57. Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice
58. Experimental investigation of herpes simplex virus latency
59. Analysis of factors influencing kinetics of herpes simplex virus transcription utilizing recombinant virus
60. Fine mapping of the latency-related gene of herpes simplex virus type 1: Alternative splicing produces distinct latency related RNAs containing open reading frames
61. A protein related to glial filaments in Schwann cells